Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$3.1M
+95.7% from 2023
Prescriptions
232
$13,466.72 per claim
Patients
48
32 prescribers
Total spending, 2024
$3.1M
$65,089.13 per patient
Medicare prescription drug plans paid $3.1M for Jemperli in 2024, for 232 prescriptions and refills to 48 patients (up 95.7% from 2023). The average cost per claim was $13,466.72.
Florida had the highest Medicare cost for Jemperli in 2024: $1.3M for 99 claims, followed by California ($495K).
Thomas J Rutherford, obstetrics & gynecology in Tampa, FL, had the highest Medicare cost for Jemperli in 2024: 43 claims costing $535K.
Jemperli is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Thomas J Rutherford Tampa, FL | Obstetrics & Gynecology | 43 | Under 11 | $535K |
| Fernando O Recio Boca Raton, FL | Gynecological Oncology | 29 | Under 11 | $354K |
| Todd D Tillmanns |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 5 | 31 | - | $361K |
| 2023 | 21 | 121 | 25 | $1.6M |
| 2024 | 32 | 232 | 48 | $3.1M |
Spending by manufacturer as listed in the spending data
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Gynecological Oncology |
| 11 |
| Under 11 |
| $197K |
| Eijean Wu Los Angeles, CA | Gynecological Oncology | 16 | Under 11 | $191K |
| Benjamin P Negin Vineland, NJ | Hematology-Oncology | 14 | Under 11 | $161K |
| Joseph P Yoe New York, NY | Hematology-Oncology | 12 | Under 11 | $129K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 232 | $3.1M |